Latest filing published 04 May 2026 for XSpray Pharma AK, €40k.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Anders Lennart Bladh, Ribbskottet is a declared insider of XSpray Pharma AK, with filings sourced from Finansinspektionen. We count 2 filings; the first trade dates from 9 September 2025 and the latest from 4 May 2026.
Every open-market trade on record is a purchase: 1 purchase worth €40k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2026, the count stands at 1 purchase and no sales.
The newest entry dates from 4 May 2026: an open-market purchase of €40k, in XSpray Pharma AK. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations